TPI-1
目录号: PL09622 纯度: ≥98.0%
CAS No. :79756-69-7
商品编号 规格 价格 会员价 是否有货 数量
PL09622-5mg 5mg ¥1928.00 请登录
PL09622-10mg 10mg ¥3375.00 请登录
PL09622-50mg 50mg ¥10447.00 请登录
PL09622-100mg 100mg ¥15269.00 请登录
PL09622-200mg 200mg 询价 询价
PL09622-500mg 500mg 询价 询价
PL09622-10mM*1mLinDMSO 10mM*1mLinDMSO ¥2121.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
TPI-1
中文别名
TPI-1
英文名称
TPI-1
英文别名
TPI-1;TPI 1;2-(2,5-dichlorophenyl)cyclohexa-2,5-diene-1,4-dione;2-(2,5-Dichlorophenyl)-1,4-benzoquinone;2,5-Cyclohexadiene-1,4-dione, 2-(2,5-dichlorophenyl)-;2',5'-Dichloro-[1,1'-biphenyl]-2,5-dione;2-(2,5-dichlorophenyl)-2,5-cyclohexadiene-1,4-dione;2-(2',5'-dichlorophenyl)-1,4-benzoquinone;CBMicro_042121;Tyrosine Phosphatase Inhibitor 1;BCP28977;NSC731240;STK338097;AK688821
Cas No.
79756-69-7
分子式
C12H6Cl2O2
分子量
253.08
包装储存
Powder -20°C 3 years;4°C 2 years
产品详情
TPI-1是SHP-1的抑制剂;抑制重组SHP-1的IC50值为40 nM。
生物活性
TPI-1, also known as Tyrosine Phosphatase Inhibitor 1, is a SHP-1 inhibitor; inhibits recombinant SHP-1 with an IC 50 of 40 nM.
性状
Solid
IC50 & Target[1][2]
IC50: 40 nM (recombinant SHP-1)
体外研究(In Vitro)
SHP-1 has been implicated as a potential cancer therapeutic target. TPI-1 is effective starting at 10 ng/mL in increasing SHP-1 phospho-substrates pLck-pY394. TPI-1 selectively increases SHP-1 phospho-substrates (pLck-pY394, pZap70 and pSlp76) in Jurkat T cells but has little effects on pERK1/2 or pLck-pY505. TPI-1 induces mouse splenic-IFNγ cells and induces IFNγ cells in human peripheral blood. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
TPI-1 inhibits the growth of B16 melanoma tumors in mice at a tolerated oral dose in a T cell-dependent manner but has little effects on B16 cell growth in culture. TPI-1 thus also increases pLck-pY394 and IFNγ cells in mice. TPI-1 also inhibits B16 tumor growth and prolongs tumor mice survival as a tolerated s.c. agent. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Kundu S, et al. Novel SHP-1 inhibitors tyrosine phosphatase inhibitor-1 and analogs with preclinical anti-tumor activities as tolerated oral agents. J Immunol. 2010 Jun 1;184(11):6529-36.
溶解度数据
In Vitro: DMSO : 50 mg/mL (197.57 mM; Need ultrasonic)H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2